HGH Fragment 176-191 5 mg research-grade lyophilized peptide powder in a glass vial. This peptide, also known as AOD9604, represents the C-terminal fragment of human growth hormone (hGH) and is studied primarily for its lipolytic properties.
Research Use Only: All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.
RESEARCH GRADE
HGH Fragment 176-191 5 mg
Form
Lyophilized peptide powder
Content
5 mg HGH Fragment 176-191 per vial
Packaging
Glass vial with sterile closure
Storage
Store lyophilized at 2–8 °C (desiccated, protect from light)
Molecular formula
$C_{78}H_{125}N_{23}O_{23}S_2$
Molecular weight
~1817.1 g·mol⁻¹
Sequence
Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
CAS number
221231-10-3 (as AOD9604)
Tests
HGH Fragment 176-191 test
What is HGH Fragment 176-191?
HGH Fragment 176-191, often referred to as AOD9604, is a modified peptide fragment corresponding to the amino acids 176-191 of the C-terminal region of human growth hormone (hGH). It has been specifically investigated for its ability to mimic the fat-reducing effects of hGH without stimulating IGF-1 levels, affecting insulin sensitivity, or promoting cell proliferation.
In laboratory studies, HGH Fragment 176-191 is associated with research into:
- lipolysis (breakdown of fat) and fat oxidation
- inhibition of lipogenesis (formation of fat)
- metabolic effects related to obesity models
- potential cartilage repair properties
- effects independent of IGF-1 signaling
